Top 10 Update: Therapy for Peanut Allergies
In October 2019, “Therapy for Peanut Allergies” took the fourth spot on Cleveland Clinic’s Top 10 list of Medical Innovations expected to make an impact in healthcare in the year 2020. A novel concept, the oral biologic is a peanut-derived drug that delivers a target daily maintenance dose of 300 milligrams of peanut protein to those with allergies. Under the close watch of a medical professional, individuals build a tolerance to peanuts, ultimately allowing them to be more confident in their food choices, and handle accidental exposure without issue.
Precision Health & the AI Imperative
At MIS2019, Precision Health & the AI Imperative aimed to uncover the people, processes, and infrastructure needed to be ready for AI’s big impact in healthcare. David Karow, MD, PhD, President & Chief Innovation Officer, Human Longevity, Inc.; Steve Kearney, Chief Medical Officer, SAS; and Michael Howell, MD, PhD, Chief Clinical Strategist, Google Health took the stage to showcase their companies’ perspectives on, and experience with, AI in healthcare.
The Breakthrough – ATAC
The ability to identify and measure ocular inflammation is vital in the management of eye diseases. It is particularly important in the areas of uveitis (the fourth leading cause of blindness worldwide) and post cataract surgery (most common ophthalmic surgery). Currently, ocular inflammation is measured via clinical examination through a slit lamp microscope or indirect ophthalmoscope. These methods are subject to clinical interpretation and variability between observers.